Navigation Links
Golden Meditech Brings in Financial Investor Through New Share Issuance

HONG KONG, Nov. 27 /PRNewswire-Asia-FirstCall/ -- China's leading integrated medical device and healthcare services provider, Golden Meditech Company Limited ("Golden Meditech" or "the Company", Stock Code: 8180.HK) is pleased to announce today that the Company has successfully brought in Atlantis Investment Management Limited ("Atlantis Investment") as financial investors through an allocation of 60 million new ordinary shares at a price HK$1.03 per share.

Mr. KAM Yuen, Chairman and CEO of Golden Meditech, said that despite the global financial crisis has caused extreme volatility in the capital market that resulted in numerous companies' fundamentals being casually ignored, Golden Meditech has demonstrated its ability to bring in new financial investor. It represents a vote of confidence from the investment community and a conviction of Golden Meditech strong fundamentals and promising outlook which was temporarily overshadowed by the pessimism in the capital market.

"We are honored to see that Atlantis Investment shares the same vision as we do with China's burgeoning healthcare industry and such a strategic investor-ship will not only strengthen Golden Meditech shareholders base, but also be beneficial to our long-term growth," said Mr. KAM.

"To act in the best interest of our shareholders, Golden Meditech has always been striving to maximize shareholders value. While enhancing the shareholder value, we also engage in various defensive measures, including share repurchases, for the purpose of preserving shareholder value," said Mr. KAM.

The net proceeds raised will be used for general working capital, and to fund future investment opportunities.

As of September 20, 2008, Golden Meditech reported sustained high growth of key businesses and recorded revenues of HK$241 million in the first half of financial year 2008/09, representing a 27% growth on a year on year basis. Net profit attributable to shareholders of the same period was HK$147 million.

Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical devices, cord blood banking services and natural herbal medicines have all established dominant positions in their own sectors. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.

Atlantis Investment Management Limited: an independent Asian equity asset management firm with over US$4.5bn under management as at January 31, 2008, with a focus on China and the Asia-Pacific countries.

    For inquiries, please kindly contact:

     Investor Relations Division
     Golden Meditech Company Limited
     Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong.
     Tel:     +852-3605-8138
     Fax:     +852-3605-8181

SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Meditech Releases FY2008/09 Interim Results
2. Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
3. U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes
4. Dataline Announces Participation in Operation Golden Phoenix
5. Golden Meditech Pioneers into Chinas Hospital Market
6. Golden Gate University Opens New Student Services Center
7. Golden Meditech Donates HKD 4 Million to Earthquake Victims
8. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
9. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
10. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
11. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
Post Your Comments:
(Date:11/29/2015)... , ... November 29, 2015 , ... Effective immediately, every ... In addition starting on Black Friday Target is offering a “Buy One Scrub Set, ... is a rare opportunity to purchase IguanaMed at a discounted price. , ...
(Date:11/28/2015)... ... 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... savings of up to 20% off orders $80 or more to free gifts with purchases, ... hours. , As a competitive e-commerce website for skin care and cosmetic needs, customers will ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, while ... light of the recent terrorist attacks in Paris, other cities are taking extra precautions ... reaching U.S. soil. Especially around special events that may be high-profile in nature, the ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced today ... Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics SL ... users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Países Bajos, November 26, 2015 ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... con la terapia fotodinámica de Bremachlorin para el cáncer ... enfoque combina la inmunoterapia con la terapia fotodinámica de ... Clinical Cancer Research . --> Clinical Cancer ...
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
Breaking Medicine Technology: